Artificial Intelligence | Machine Learning | Machine Perception HeartSciences | Early Detection of Cardiac Dysfunction


Consumer, Enterprise, Healthcare, Medical Device, Health Diagnostics, Heart Disease Screening, ECG, AI Southlake, TX, United States

HeartSciences

Artificial Intelligence | Machine Learning | Machine Perception


HeartSciences | Early Detection of Cardiac Dysfunction

HeartSciences

Healthcare, Medical Device, Health Diagnostics, Heart Disease Screening, ECG, AI


Southlake, TX, United States

HeartSciences is advancing the field of electrocardiography through the application of wavelet signal processing and artificial intelligence to develop next-generation ECG technology. Wavelet signal processing is currently used in many different industries as an important tool to provide insights and new valuable data related to spectral analysis of a signal. HeartSciences’ MyoVista wavECG Cardiac Testing Device is a 12-lead resting electrocardiograph utilizing continuous wavelet transform (CWT) based signal processing. Patented informatics focus on energy-related information rather than conventional voltage-based information. HeartSciences' mission is to enable accurate, affordable screening for the early detection of heart disease.

 

B2B2C, B2B

51 to 100

Funded

$28,198,000

Scaling Up

2008

 
 

Medical Devices
Healthcare

N/A

Increase Efficiency
Healthcare

 
 

Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


Smart Medical Devices

Smart Medical Devices

Health Care Systems

Health Care Systems


Image

Image

Video

Video

Audio

Audio

Text

Text

Time Series

Time Series

 

   Software & Hardware


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 
Mark Hilz


Mark Hilz
President/CEO

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ HeartSciences